Skip to main content
Fig. 3 | Systematic Reviews

Fig. 3

From: Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction

Fig. 3

Distribution of the individual-level relative effects of β2-agonists on exercise-induced FEV1 declines. This figure is limited to 159 participants who had ≥10% decline in FEV1 by exercise in the placebo test. Participants with small FEV1 declines are not informative in the calculation of participant-level relative effect. In addition, the 10% limit is usual for the diagnosis of exercise-induced bronchoconstriction [12]. Participant X of Figs. 1 and 2 has value 0.58 (58%) in this figure. As in Fig. 2, some participants showed β2-agonist effects below 0% or over 100%

Back to article page